Progesterone receptor modulators for endometriosis-Reference-Cited by-同舟云学术

Progesterone receptor modulators for endometriosis

Published:2017-07-25 Issue:7 Volume:2017 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Fu Jing¹,Song Hao¹²,Zhou Min¹,Zhu Huili¹,Wang Yuhe¹,Chen Hengxi¹,Huang Wei¹

Affiliation:

1. West China Second University Hospital, Sichuan University; Department of Obstetrics and Gynecology; Chengdu Sichuan China

2. Ministry of Education; Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University); Chengdu China

Publisher

Wiley

Subject

Pharmacology (medical)

Reference42 articles.

1. A multicentre comparative study of gestrinone and danazol in the treatment of endometriosis;Bromham;Journal of Obstetrics and Gynaecology,1995

2. Updating the clinical experience in endometriosis - the European perspective;Bromham;British Journal of Obstetrics and Gynaecology,1995

3. Treatment with 5 mg or 25 mg of mifepristone daily for six months. A randomized double-blind study;Carbonell;Progresos de Obstetricia y Ginecologia,2012

4. Mifepristone 2.5, 5, 10 mg versus placebo in the treatment of endometriosis;Carbonell;Journal of Reproductive Health and Medicine,2016

5. Treatment of endometriosis with the novel selective progesterone receptor modulator (SPRM) asoprisnil;Chwalisz;Fertility and Sterility,2004

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medical management of endometriosis;Current Opinion in Obstetrics & Gynecology;2024-08-17

2. Treatment of endometriosis with mifepristone mediated by nanostructured lipid carriers;Drug Delivery and Translational Research;2024-07-11

3. A comprehensive review comparing conventional versus traditional remedies in the treatment of endometriosis with futuristic insights;Future Journal of Pharmaceutical Sciences;2024-03-05

4. Medikamentöse Therapie der Endometriose;Die Gynäkologie;2024-01-30

5. Clinical Efficacy, Pharmacokinetics, and Safety of the Available Medical Options in the Treatment of Endometriosis-Related Pelvic Pain: A Scoping Review;Pharmaceuticals;2023-09-18